JP2005534326A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005534326A5 JP2005534326A5 JP2004526814A JP2004526814A JP2005534326A5 JP 2005534326 A5 JP2005534326 A5 JP 2005534326A5 JP 2004526814 A JP2004526814 A JP 2004526814A JP 2004526814 A JP2004526814 A JP 2004526814A JP 2005534326 A5 JP2005534326 A5 JP 2005534326A5
- Authority
- JP
- Japan
- Prior art keywords
- host range
- range gene
- gene
- cell
- homologue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 241000700618 Vaccinia virus Species 0.000 claims 2
- 241000271566 Aves Species 0.000 claims 1
- 101150091263 E3L gene Proteins 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200201189 | 2002-08-07 | ||
| PCT/EP2003/008359 WO2004015118A1 (en) | 2002-08-07 | 2003-07-29 | Vaccinia virus host range genes to increase the titer of avipoxviruses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005534326A JP2005534326A (ja) | 2005-11-17 |
| JP2005534326A5 true JP2005534326A5 (https=) | 2006-09-07 |
Family
ID=31502636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004526814A Pending JP2005534326A (ja) | 2002-08-07 | 2003-07-29 | アビポックスウイルスの力価を増加させるためのワクシニアウイルス宿主域遺伝子 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7473536B2 (https=) |
| EP (2) | EP2264178A1 (https=) |
| JP (1) | JP2005534326A (https=) |
| AT (1) | ATE504653T1 (https=) |
| AU (1) | AU2003255315A1 (https=) |
| CA (1) | CA2489301A1 (https=) |
| DE (1) | DE60336653D1 (https=) |
| WO (1) | WO2004015118A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7501127B2 (en) | 2002-05-16 | 2009-03-10 | Bavarian Nordic A/S | Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara |
| WO2004015118A1 (en) * | 2002-08-07 | 2004-02-19 | Bavarian Nordic A/S | Vaccinia virus host range genes to increase the titer of avipoxviruses |
| EP1528101A1 (en) | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
| DK1536015T3 (da) * | 2003-11-24 | 2008-02-18 | Bavarian Nordic As | Promotorer til ekspression i modificeret vacciniavirus Ankara |
| ES2315096B1 (es) * | 2006-05-13 | 2009-12-30 | Consejo Superior De Investigaciones Cientificas | Vectores en los que se inserta el gen c7l y uso de los mismos en la fabricacion de vacunas y de composiciones para terapia genica. |
| CA2670804A1 (en) * | 2006-05-19 | 2007-11-29 | Sanofi Pasteur Inc. | Immunological composition |
| EP2424999A1 (en) | 2009-04-30 | 2012-03-07 | Centre Hospitalier Universitaire Vaudois Lausanne (CHUV) | Modified immunization vectors |
| US20140093556A1 (en) | 2011-01-28 | 2014-04-03 | Sanofi Pasteur Sa | Immunological Compositions Against HIV |
| WO2014140938A2 (en) | 2013-03-14 | 2014-09-18 | Centre Hospitalier Universitaire Vaudois | Immunological methods |
| RS57290B1 (sr) * | 2013-11-01 | 2018-08-31 | Sementis Ltd | Proizvodnja virusnih vektora |
| EP3833367A4 (en) | 2018-08-08 | 2022-05-11 | Arizona Board of Regents on behalf of Arizona State University | Method for improved poxvirus yields |
| US20240309335A1 (en) * | 2021-06-30 | 2024-09-19 | Repli-Tech Co., Ltd. | Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE787901A (fr) | 1971-09-11 | 1972-12-18 | Freistaat Bayern Represente Pa | Vaccin antivariolique |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| US5833975A (en) | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| AU570940B2 (en) | 1982-11-30 | 1988-03-31 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Process for producing poxvirus recombinants for expression offoreign genes |
| US5766598A (en) | 1991-03-07 | 1998-06-16 | Virogenetics Corporation | Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products |
| DE69233158T2 (de) * | 1991-03-07 | 2004-05-13 | Connaught Technology Corp., Greenville | Gentechnologisch hergestellter stamm für impfstoffe |
| MY150893A (en) | 1996-09-24 | 2014-03-14 | Bavarian Nordic As | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines |
| US6004777A (en) * | 1997-03-12 | 1999-12-21 | Virogenetics Corporation | Vectors having enhanced expression, and methods of making and uses thereof |
| US5990091A (en) * | 1997-03-12 | 1999-11-23 | Virogenetics Corporation | Vectors having enhanced expression, and methods of making and uses thereof |
| US6294176B1 (en) * | 1998-07-10 | 2001-09-25 | Schering-Plough Veterinary Corp. | Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species |
| FR2811766B1 (fr) | 2000-07-13 | 2002-09-27 | Tabacs & Allumettes Ind | Procede de caracterisation de la compacite d'objets tels que des cigarettes ou des filtres |
| AU2002246829A1 (en) * | 2000-12-22 | 2002-07-30 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health A | Methods to control the host range of retroviral vectors |
| WO2004015118A1 (en) * | 2002-08-07 | 2004-02-19 | Bavarian Nordic A/S | Vaccinia virus host range genes to increase the titer of avipoxviruses |
-
2003
- 2003-07-29 WO PCT/EP2003/008359 patent/WO2004015118A1/en not_active Ceased
- 2003-07-29 US US10/524,043 patent/US7473536B2/en not_active Expired - Fee Related
- 2003-07-29 EP EP10008652A patent/EP2264178A1/en not_active Withdrawn
- 2003-07-29 EP EP03784104A patent/EP1529113B1/en not_active Expired - Lifetime
- 2003-07-29 JP JP2004526814A patent/JP2005534326A/ja active Pending
- 2003-07-29 AU AU2003255315A patent/AU2003255315A1/en not_active Abandoned
- 2003-07-29 DE DE60336653T patent/DE60336653D1/de not_active Expired - Lifetime
- 2003-07-29 CA CA002489301A patent/CA2489301A1/en not_active Abandoned
- 2003-07-29 AT AT03784104T patent/ATE504653T1/de not_active IP Right Cessation
-
2008
- 2008-08-26 US US12/198,220 patent/US20090162935A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004538039A5 (https=) | ||
| JP2005534326A5 (https=) | ||
| JP2005527336A5 (https=) | ||
| JP2007518723A5 (https=) | ||
| JP2006240292A5 (https=) | ||
| JP2006524283A5 (https=) | ||
| JP2005501532A5 (https=) | ||
| JP2005237328A5 (https=) | ||
| JP2007508034A5 (https=) | ||
| JP2003160581A5 (https=) | ||
| DK1523329T3 (da) | Viruspartikeladjuvant | |
| JP2005530695A5 (https=) | ||
| JP2009520682A5 (https=) | ||
| IS2811B (is) | Notkun á HPV16 og HPV18 veirulíkum ögnum gegn einni eða fleiri af æxlisvaldandi HPV gerðum 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 | |
| WO2003023040A3 (en) | Vaccinia virus mva-e3l-knockout-mutants and use thereof | |
| JP2007510403A5 (https=) | ||
| JP2005529611A5 (https=) | ||
| JP2006506499A5 (https=) | ||
| JP2002240244A5 (https=) | ||
| AU2003255315A1 (en) | Vaccinia virus host range genes to increase the titer of avipoxviruses | |
| JP2005517783A5 (https=) | ||
| JP2001354766A5 (https=) | ||
| JP2005536763A5 (https=) | ||
| JP2005061961A5 (https=) | ||
| JP2003284553A5 (https=) |